Application of Ultrahigh Doses of Morphine in Systemic Multiple Epithelioid Hemangioendothelioma without Addiction: A Case Report (Case Report)

HTML  XML Download Download as PDF (Size: 1150KB)  PP. 285-294  
DOI: 10.4236/crcm.2019.811035    1,095 Downloads   1,764 Views  

ABSTRACT

Morphine is a potent opioid which is commonly used for relieving cancer pain with strong analgesic properties. Epithelioid hemangioendothelioma (EHE), a rare vascular tumor that can cause severe chronic pain, is usually diagnosed in a surgical biopsy. We describe ultrahigh doses of morphine used in a case of a 17-year-old male who suffered from severe chest pain with systemic multiple EHE. The total dosage of morphine was as high as 92,530 mg given within 164 days. However, we observed no indications that the patient was addicted.

Share and Cite:

Liu, M. , Ma, M. , Ning, X. and He, R. (2019) Application of Ultrahigh Doses of Morphine in Systemic Multiple Epithelioid Hemangioendothelioma without Addiction: A Case Report. Case Reports in Clinical Medicine, 8, 285-294. doi: 10.4236/crcm.2019.811035.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.